Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2006-10-26
2010-02-23
Mondesi, Robert (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C424S185100, C424S234100, C530S300000, C530S326000
Reexamination Certificate
active
07666437
ABSTRACT:
The disclosure relates to an intranasal peptide vaccine for use against infection caused by enterotoxigenicEscherichia coli(ETEC), containing a common linear protein epitope known as CLE which is recognized by sera of patients infected with the bacteria and which is associated with a mucosal adjuvant comprising cholera toxin subunit B, known as CTB. The disclosure relates to a peptide containing twenty amino acids, which is located in the linear sequence of the CFA/I fimbria of enterotoxigenicEscherichia coli.
REFERENCES:
patent: 2003/0161889 (2003-08-01), Reid et al.
Lopez-Vidal et al. Continous and Common Epitopes Present in Fimbria. Gaceta Medica De Mexico. Nov.-Dec. 1997; 133 (6):511-525.
Arredondo Hernández Luis José
Godinez Moreno Ricardo
López Vidal Yolanda
Suaste Villanueva Olga Roxana
Miller Matthias & Hull
Mondesi Robert
Ogunbiyi Oluwatosin
Universidad Nacional Autonoma de Mexico
LandOfFree
Intranasal vaccine for use against disease caused by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intranasal vaccine for use against disease caused by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intranasal vaccine for use against disease caused by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4229428